Moreover, drugs with greater efficacy are being developed by combining two or three of GLP-1 and GIP or glucagon or amylin
doi 10.1007/s40264-023-01392-3 109 BestWRBecktelJMSingletonJWKernF
However, recent research suggests they may also reduce cravings for alcohol and other addictive substances by influencing the dopamine reward system in the brain
Additionally, their associated benefits of reduced blood glucose content (glycemia), kidney disease, fatty liver, and improved cardiovascular functioning make them a viable alternative to conventional bariatric surgery and underscore significant medical advances in combatting obesity
[DOI] [PMC free article] [PubMed] [Google Scholar] 101.Dunlay SM, et al
GLP-1 medications (like Ozempic and Wegovy) manage Type 2 diabetes and obesity